HAL (France)
open access
Gompertz growth with a shared carrying capacity optimally simulates primary and metastatic tumor growth dynamics
Statement of Significance: Metastatic cancer is a systemic disease. Local treatments have systemic effects. Understanding the systemic interplay between tumors is important. This study provides an innovative modeling framework and experimental insights for these phenomena.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors#1139699
- Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer#1163770
- A Study of Sofe-M in Participants With Selected Advanced Solid Tumors#1184695
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer#1153311
- A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer#890421
Record · ID 1203619
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive